Joseph Scattergood is currently the Vice President of Oncology Clinical Trial Enrollment Expansion at Eli Lilly and Company, a role they have held since 2024. Previously, they served in various leadership roles at Eli Lilly, including Senior Director for the Oncology Asset Lead and Vice President for Oncology Discovery and Early Phase Program Management. Joseph's experience also includes positions at Memorial Sloan-Kettering Cancer Center and AbbVie, where they contributed to clinical trials and global marketing strategies. They hold an AB in Psychology and Hispanic Literature & Culture from Brown University and an MBA in Healthcare Management and Marketing from the University of Pennsylvania's Wharton School.
This person is not in any teams
This person is not in any offices